Rising prescription brand-name drugs are raising insurance premiums to unaffordable heights, ... The existing world of multiple prices and multiple discounts, and great amounts of complexity and paper work, harm ordinary American patients, businesses and taxpayers.

They have been debating for a year the question of covering everyone . . . and yet it appears that the legislative compromise will only provide $144 million through the new employer assessment . . . in its first three years.

As brand-name-drug makers raise prices, generic-drug makers will find room to boost their prices to compete for market share.

Generic drugs are a side show in a circus, ... They attract a lot of attention, but the main event is the big tent - the brand-name drug makers.

This report card does not offer valid ground for reassurance. We have closed half of our hospitals since President Kennedy was inaugurated. In some parts of the state, it means substantially greater travel time to the emergency room.

The law doesn't provide remotely enough to finance affordable decent coverage.